Rockefeller Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-1,421
| Closed | -$111K | – | 463 |
|
|
2016
Q2 | $111K | Buy |
+1,421
| New | +$111K | ﹤0.01% | 350 |
|
|
2015
Q3 | – | Sell |
-2,126
| Closed | -$291K | – | 513 |
|
|
2015
Q2 | $291K | Sell |
2,126
-1,429
| -40% | -$196K | 0.01% | 282 |
|
|
2015
Q1 | $443K | Sell |
3,555
-220
| -6% | -$27.4K | 0.01% | 257 |
|
|
2014
Q4 | $341K | Sell |
3,775
-310
| -8% | -$28K | 0.01% | 269 |
|
|
2014
Q3 | $295K | Buy |
+4,085
| New | +$295K | 0.01% | 295 |
|
|
2014
Q1 | – | Sell |
-409,644
| Closed | -$28.8M | – | 510 |
|
|
2013
Q4 | $28.8M | Sell |
409,644
-19,176
| -4% | -$1.35M | 0.62% | 50 |
|
|
2013
Q3 | $30.9M | Sell |
428,820
-74,932
| -15% | -$5.41M | 0.72% | 49 |
|
|
2013
Q2 | $28.1M | Buy |
+503,752
| New | +$28.1M | 0.67% | 48 |
|